Abstract
BackgroundThe CAR T cell therapy initiated as a treatment for CD19+ malignant B cell has rapidly expanded to many other cancers including solid tumors. Among multiple key factors to improve...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have